The Global Transcatheter Aortic Valve Replacement Market Size is growing at a CAGR of ~15.41% by 2032, estimates DelveInsight

DelveInsight's Transcatheter Aortic Valve Replacement Market Insights Report 2032 provides the current and forecast market analysis, individual leading Transcatheter Aortic Valve Replacement Companies market shares, challenges, Transcatheter Aortic Valve Replacement Market Drivers, barriers, trends, and key market Transcatheter Aortic Valve Replacement companies in the market.

To read more about the latest highlights related to the Transcatheter Aortic Valve Replacement Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/transcatheter-aortic-valve-replacement-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Transcatheter Aortic Valve Replacement Market Report
• In May 2025, Edwards Lifesciences announced that the U.S. Food and Drug Administration (FDA) has approved its SAPIEN 3 transcatheter aortic valve replacement (TAVR) therapy for use in severe aortic stenosis (AS) patients without symptoms. This approval marks the first time TAVR has been authorized for asymptomatic patients, expanding treatment options for individuals with severe AS.
• In April 2025, SoloPace Incorporated announced FDA clearance and the first use of its SoloPace control system for temporary pacing in transcatheter aortic valve implantation (TAVI) procedures. The system aims to enhance pacing efficiency and reduce patient risks, with initial cases completed at Scripps Clinic in San Diego.
• In March 2025, Medtronic plc (NYSE: MDT) announced late-breaking five-year data from the Evolut Low Risk Trial. The results show that, compared to surgery, the EvolutTM transcatheter aortic valve replacement (TAVR) system offers a numerically lower rate of all-cause mortality or disabling stroke at five years, along with strong valve performance and durable clinical outcomes.
• The Global Transcatheter Aortic Valve Replacement Market is expected to increase from ~USD 3.23 Billion in 2024 to ~USD 7.64 Billion by 2032, reflecting strong and sustained growth.
• The Global Transcatheter Aortic Valve Replacement Market is growing at a CAGR of ~15.41% during the forecast period from 2025 to 2032.
• North America is expected to account for the significant market revenue share in the transcatheter aortic valve replacement devices market. North America is expected to dominate the global market and would continue to maintain its dominance in revenue generation in the transcatheter aortic valve replacement devices market during the forecast period.
• The leading Transcatheter Aortic Valve Replacement Companies such as Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, Transcatheter Technologies GmbH, Braile Biomedica, Venus Medtech, Direct Flow Medical, Sorin group, Blue Sail Medical Co. Ltd., JC Medical Inc., Cook Medical Inc., Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, and P+F Products + Features GmbH and others.

To know more about why North America is leading the market growth in the Transcatheter Aortic Valve Replacement Market, get a snapshot @ https://www.delveinsight.com/sample-request/transcatheter-aortic-valve-replacement-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Transcatheter Aortic Valve Replacement Market Dynamics
The transcatheter aortic valve replacement devices market is witnessing an increase in product demand owing to numerous reasons and one of the key aspects being the rising prevalence of aortic stenosis disorder. According to the World Health Organization 2020, the prevalence of calcific aortic valve stenosis had been found to be 9 million across the world. Also, as per the John Muir Health statistics, in the year 2020, about 1.5 million people in the United States tend to suffer from aortic stenosis and about 500,000 people within this group of patients tend to suffer from severe aortic stenosis. As per the same source in 2020, about 250,000 patients suffering from aortic stenosis were symptomatic in the United States.

Transcatheter Aortic Valve Replacement Market Segmentation Analysis
Transcatheter Aortic Valve Replacement Devices Market By Material [Valve Frame Material (Nitinol, Stainless Steel, Cobalt Chromium and Others), Valve Leaflet Material (Porcine, Bovine and Others)], By Procedure (Transfemoral, Transapical and Transaortic Approach), By Application (Aortic Stenosis, Aortic Regurgitation and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Get a sneak peek at the Transcatheter Aortic Valve Replacement Market Dynamics @ Transcatheter Aortic Valve Replacement Market Dynamics Analysis- https://www.delveinsight.com/sample-request/transcatheter-aortic-valve-replacement-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Transcatheter Aortic Valve Replacement Companies
Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, Transcatheter Technologies GmbH, Braile Biomedica, Venus Medtech, Direct Flow Medical, Sorin group, Blue Sail Medical Co. Ltd., JC Medical Inc., Cook Medical Inc., Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, and P+F Products + Features GmbH and others.

Transcatheter Aortic Valve Replacement Market Drivers
The demand for transcatheter aortic valve replacement devices is primarily being boosted by the rising prevalence of aortic stenosis, rising prevalence of cardiovascular disorders, increase in aortic stenosis disorder, rising numbers of aortic regurgitation amongst the population, and increasing TAVR procedures which are expected to increase in the product demand thereby contributing in the growth of the transcatheter aortic valve replacement devices market during the forecast period from 2024-2032.

Which MedTech key players in the Transcatheter Aortic Valve Replacement Market are set to emerge as the trendsetter explore @ Transcatheter Aortic Valve Replacement Companies- https://www.delveinsight.com/sample-request/transcatheter-aortic-valve-replacement-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Transcatheter Aortic Valve Replacement Market Report
• Coverage- Global
• Forecast Period- 2025-2032
• Transcatheter Aortic Valve Replacement Companies- Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, Transcatheter Technologies GmbH, Braile Biomedica, Venus Medtech, Direct Flow Medical, Sorin group, Blue Sail Medical Co. Ltd., JC Medical Inc., Cook Medical Inc., Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, and P+F Products + Features GmbH and others.

Interested in knowing the Transcatheter Aortic Valve Replacement Market by 2032? Click to get a snapshot of the Transcatheter Aortic Valve Replacement Market Trends- https://www.delveinsight.com/sample-request/transcatheter-aortic-valve-replacement-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Transcatheter Aortic Valve Replacement Market Report Introduction
2. Transcatheter Aortic Valve Replacement Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Transcatheter Aortic Valve Replacement Market Key Factors Analysis
6. Transcatheter Aortic Valve Replacement Market Porter's Five Forces Analysis
7. Transcatheter Aortic Valve Replacement Market Assessment
8. Transcatheter Aortic Valve Replacement Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

About Us

DelveInsight is a leading focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and pharma sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.